2 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Eye Abnormalities: new trials by email Literature Review of Eye Abnormalities trials Research Report on Eye Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. sepofarsen - Leber Congenital Amaurosis 10, Blindness | Phase 2 / Phase 3 | Unknown | ProQR Therapeutics | 15 | 2021-03-23 | 2022-03-25 |
| Prosthetic Motility and Complications in Pegged Versus Unpegged Hydroxyapatite Orbital Implants orbital implant - Anophthalmos, Orbital Implants | Phase 2 / Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 50 | 2005-11-01 | 2010-05-12 |
Anophthalmos (1) · Blindness (1) · Eye Diseases (1) · Leber Congenital Amaurosis (1) · Leber Congenital Amaurosis 10 (1) · Meckel Syndrome, Type 4 (1) · Neurologic Manifestations (1) · Retinal Degeneration (1) · Retinal Diseases (1) · Retinal Dystrophies (1) · Sensation Disorders (1) · Vision Disorders (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Nervous System Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Orbital Implants (1)
ProQR Therapeutics (1) · Shahid Beheshti University of Medical Sciences (1)
Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · Iran (1) · Italy (1) · Netherlands (1) · United Kingdom (1)